Feucht HE - Search Results

1

Humoral alloreactivity in recipients of renal allografts as a risk factor for the development of delayed graft function.

Feucht HE, Lederer SR, Kluth B. Feucht HE, et al. Transplantation. 1998 Mar 15;65(5):757-8. doi: 10.1097/00007890-199803150-00029. Transplantation. 1998. PMID: 9521218 No abstract available.

2

Impact of humoral alloreactivity on the survival of renal allografts.

Kluth-Pepper B, Schneeberger H, Lederer SR, Albert E, Land W, Feucht HE. Kluth-Pepper B, et al. Among authors: feucht he. Transplant Proc. 1998 Aug;30(5):1772. doi: 10.1016/s0041-1345(98)00424-2. Transplant Proc. 1998. PMID: 9723275 No abstract available.

3

Early renal graft dysfunction. The role of preformed antibodies to DR-typed lymphoblastoid cell lines.

Lederer SR, Schneeberger H, Albert E, Johnson JP, Gruber R, Land W, Burkhardt K, Hillebrand G, Feucht HE. Lederer SR, et al. Among authors: feucht he. Transplantation. 1996 Jan 27;61(2):313-9. doi: 10.1097/00007890-199601270-00025. Transplantation. 1996. PMID: 8600642

4

Impact of humoral alloreactivity early after transplantation on the long-term survival of renal allografts.

Lederer SR, Kluth-Pepper B, Schneeberger H, Albert E, Land W, Feucht HE. Lederer SR, et al. Among authors: feucht he. Kidney Int. 2001 Jan;59(1):334-41. doi: 10.1046/j.1523-1755.2001.00495.x. Kidney Int. 2001. PMID: 11135088 Free article.

5

Endothelial expression of CD40 in renal cell carcinoma.

Kluth B, Hess S, Engelmann H, Schafnitzel S, Riethmüller G, Feucht HE. Kluth B, et al. Among authors: feucht he. Cancer Res. 1997 Mar 1;57(5):891-9. Cancer Res. 1997. PMID: 9041191

6

Increased antibody titers against mycobacterial heat-shock protein 65 in patients with vasculitis and arteriosclerosis.

Gruber R, Lederer S, Bechtel U, Lob S, Riethmüller G, Feucht HE. Gruber R, et al. Among authors: feucht he. Int Arch Allergy Immunol. 1996 May;110(1):95-8. doi: 10.1159/000237318. Int Arch Allergy Immunol. 1996. PMID: 8645986

7

Complement C4d in graft capillaries -- the missing link in the recognition of humoral alloreactivity.

Feucht HE. Feucht HE. Am J Transplant. 2003 Jun;3(6):646-52. doi: 10.1034/j.1600-6143.2003.00171.x. Am J Transplant. 2003. PMID: 12780555 Free article. Review.

8

Incidence of humoral rejection in heart transplant recipients treated with tacrolimus or cyclosporine A.

Behr TM, Richter K, Fischer P, Spes CH, Meiser B, Reichart B, Pongratz D, Feucht H, Theisen K, Angermann CE. Behr TM, et al. Transplant Proc. 1998 Aug;30(5):1920-1. doi: 10.1016/s0041-1345(98)00482-5. Transplant Proc. 1998. PMID: 9723333 No abstract available.

9

Assessment of soluble adhesion molecules (sICAM-1, sVCAM-1, sELAM-1) and complement cleavage products (sC4d, sC5b-9) in urine. Clinical monitoring of renal allograft recipients.

Bechtel U, Scheuer R, Landgraf R, König A, Feucht HE. Bechtel U, et al. Among authors: feucht he. Transplantation. 1994 Oct 27;58(8):905-11. doi: 10.1097/00007890-199410270-00008. Transplantation. 1994. PMID: 7524208

10

Vascular rejection episodes reduce success in renal graft outcome after therapy with BMA 031.

Hillebrand G, Dendorfer U, Feucht HE, Brockmeyer C, Gokel JM, Illner WD, Abendroth D, Kasper C, Land W. Hillebrand G, et al. Among authors: feucht he. Transplant Proc. 1991 Feb;23(1 Pt 2):1092-3. Transplant Proc. 1991. PMID: 1989156 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters